Le Lézard
Classified in: Science and technology, Business
Subject: VEN

Databricks Raises Series I Investment at $43B Valuation


Round led by T. Rowe Price, joined by new investors Capital One Ventures, Ontario Teachers' Pension Plan and strategic investor NVIDIA

SAN FRANCISCO, Sept. 14, 2023 /CNW/ -- Databricks, the Data and AI company, today announced its Series I funding, raising over $500 million. This funding values the company at $43 billion and establishes the price per share at $73.50. The series is led by funds and accounts advised by T. Rowe Price Associates, Inc., which is joined by other existing investors, including Andreessen Horowitz, Baillie Gifford, ClearBridge Investments, funds and accounts managed by Counterpoint Global (Morgan Stanley), Fidelity Management & Research Company, Franklin Templeton, GIC, Octahedron Capital and Tiger Global along with new investors Capital One Ventures, Ontario Teachers' Pension Plan and NVIDIA.

"The commitment from long-term focused strategic and financial partners reflects Databricks' continued momentum, the rapid customer adoption of the Databricks Lakehouse, and the success customers are seeing from moving to a unified data and AI platform," said Ali Ghodsi, Co-Founder and CEO of Databricks. "Databricks and NVIDIA are building transformative AI technology, and we're excited about the business value and innovation we can bring to our customers."

The Databricks Lakehouse unifies data, analytics and AI on a single platform so that customers can govern, manage and derive insights from enterprise data and build their own generative AI solutions faster.

"Enterprise data is a goldmine for generative AI," said Jensen Huang, founder and CEO of NVIDIA. "Databricks is doing incredible work with NVIDIA technology to accelerate data processing and generative AI models."

"Data and AI have rapidly become the centerpiece of many business strategies. Databricks has not only pioneered the Lakehouse category with a world-class team and product, but it is now also at the forefront of Generative AI for the enterprise. We're proud to extend our investment at such a pivotal time for the company, its customers, and the data and AI industry." ? Alan Tu, Lead Private Equity Analyst, T. Rowe Price Associates, Inc.

"Teachers' Venture Growth is excited to invest in Databricks and sees tremendous growth potential for the business as enterprises increasingly deploy AI across their operations. As investors focused on long-term value creation, we look forward to working with Ali and Databricks' strong management team on the next phase of their growth journey." ? Olivia Steedman, Executive Managing Director, Teachers' Venture Growth at Ontario Teachers'  

The support from Databricks' financial and strategic partners comes on the heels of its Q2 momentum (ended July 31, 2023), which includes:

About Databricks
Databricks is the Data and AI company. More than 10,000 organizations worldwide ? including Comcast, Condé Nast, and over 50% of the Fortune 500 ? rely on the Databricks Lakehouse Platform to unify their data, analytics and AI. Founded by the original creators of Delta Lake, Apache Sparktm, and MLflow, Databricks is on a mission to help data teams solve the world's toughest problems. To learn more, follow Databricks on Twitter, LinkedIn, and Facebook.

Contact: [email protected] 

 

SOURCE Databricks


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: